HIFU-Enhanced Transdermal Delivery of Hyaluronic-Acid-Functionalized Solid Lipid Nanoparticles for Localized Melanoma Therapy

Abstract Cutaneous melanoma is an aggressive skin cancer for which localized treatment remains difficult because of limited drug penetration through the stratum corneum and the systemic toxicity of conventional chemotherapy. Here, we developed a noninvasive physicochemical platform combining hyaluronic acid (HA)-functionalized paclitaxel-loaded solid lipid nanoparticles (SLNs) with high-intensity focused ultrasound (HIFU) for localized melanoma therapy. The optimized SLNs exhibited a hydrodynamic diameter of 134.6 ± 4.2 nm and a zeta potential of –22.3 ± 1.5 mV. HIFU induced changes in the structural organization of the lipid matrix, accelerating paclitaxel release and enhancing skin penetration. In vitro, SLNs with HIFU reduced B16F10 melanoma cell viability to below 20% while maintaining approximately 65% viability of HaCaT keratinocytes. The combined treatment increased intracellular ROS generation by 6.2-fold and enhanced apoptotic signaling. In ex vivo porcine skin, HIFU-assisted delivery of coumarin-6-loaded SLNs increased fluorescence penetration to approximately 1500 μm, compared with 750 μm without HIFU. In B16F10 tumor-bearing mice, topical SLNs combined with HIFU under mild hyperthermia (41–43 °C) achieved 90.1% tumor growth inhibition at Day 8, 81.5% tumor necrosis, and 86.5% TUNEL-positive cells without significant body-weight loss or treatment-related toxicity. These findings support HIFU-enhanced SLNs as a potential strategy for improving cutaneous paclitaxel delivery and suppressing localized melanoma growth.

Authors

Institutions

Publication Details

Journal
ACS Applied Materials & Interfaces
Published
2026-11-14
DOI
https://doi.org/10.1021/acsami.6c18357
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

HIFU-Enhanced Transdermal Delivery of Hyaluronic-Acid-Functionalized Solid Lipid Nanoparticles for Localized Melanoma Therapy

Ki Su Kim, Yuon Song, Tae Eon Park, Jeesu Kim
ACS Applied Materials & Interfaces
Advancements in Transdermal Drug Delivery
article

HIFU-Enhanced Transdermal Delivery of Hyaluronic-Acid-Functionalized Solid Lipid Nanoparticles for Localized Melanoma Therapy

Ki Su Kim, Yuon Song, Tae Eon Park, Jeesu Kim
article en

Abstract

Abstract Cutaneous melanoma is an aggressive skin cancer for which localized treatment remains difficult because of limited drug penetration through the stratum corneum and the systemic toxicity of conventional chemotherapy. Here, we developed a noninvasive physicochemical platform combining hyaluronic acid (HA)-functionalized paclitaxel-loaded solid lipid nanoparticles (SLNs) with high-intensity focused ultrasound (HIFU) for localized melanoma therapy. The optimized SLNs exhibited a hydrodynamic diameter of 134.6 ± 4.2 nm and a zeta potential of –22.3 ± 1.5 mV. HIFU induced changes in the structural organization of the lipid matrix, accelerating paclitaxel release and enhancing skin penetration. In vitro, SLNs with HIFU reduced B16F10 melanoma cell viability to below 20% while maintaining approximately 65% viability of HaCaT keratinocytes. The combined treatment increased intracellular ROS generation by 6.2-fold and enhanced apoptotic signaling. In ex vivo porcine skin, HIFU-assisted delivery of coumarin-6-loaded SLNs increased fluorescence penetration to approximately 1500 μm, compared with 750 μm without HIFU. In B16F10 tumor-bearing mice, topical SLNs combined with HIFU under mild hyperthermia (41–43 °C) achieved 90.1% tumor growth inhibition at Day 8, 81.5% tumor necrosis, and 86.5% TUNEL-positive cells without significant body-weight loss or treatment-related toxicity. These findings support HIFU-enhanced SLNs as a potential strategy for improving cutaneous paclitaxel delivery and suppressing localized melanoma growth.

ACS Applied Materials & Interfaces
Hanyang University (KR), Pusan National University (KR)
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon